Importantly, mutations in BCR signaling components can lead to uncontrolled activation of signaling, and dysregulation of BCR signaling has been implicated in the development of lymphoid malignancies and autoimmune disorders (Hasler & Zouali, 2001; Young & Staudt, 2013). The gene discussed is BCR; the disease is Autoimmunity.